Melissa Starovasnik
Director/Board Member bij TWIST BIOSCIENCE CORPORATION
Vermogen: 674 020 $ op 29-02-2024
Profiel
Melissa A.
Starovasnik is on the board of Twist Bioscience Corp.
She previously occupied the position of Vice President-Protein Sciences at Genentech, Inc.
She received an undergraduate degree and a doctorate from the University of Washington.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TWIST BIOSCIENCE CORP.
0.03% | 06-02-2024 | 17 155 ( 0.03% ) | 674 020 $ | 29-02-2024 |
Actieve functies van Melissa Starovasnik
Bedrijven | Functie | Begin |
---|---|---|
TWIST BIOSCIENCE CORPORATION | Director/Board Member | 06-08-2021 |
Eerdere bekende functies van Melissa Starovasnik
Bedrijven | Functie | Einde |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Melissa Starovasnik
University of Washington | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TWIST BIOSCIENCE CORPORATION | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |